Hakutulokset - Nigel S. Key

Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria Tekijä Ming Y. Lim, Keith E. Volmar, Nigel S. Key

Hae kokoteksti

Relationships between bleeding assessment tools (ISTH-BAT, Self-BAT) and quality of life in patients with bleeding symptoms Tekijä Callie Berkowitz, Supreet K. Goraya, Angela M. Stover, Marcella H. Boynton, Alice Ma, Nigel S. Key

Hae kokoteksti

Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause Tekijä Callie Berkowitz, Alice Ma, Vanessa Miller, Supreet Goraya, Kristi Kirkland, Julie Grabell, Nigel S. Key, Paula D. James

Hae kokoteksti

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B Tekijä Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W.G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe

Hae kokoteksti

Erratum to “Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome” [Kidney International Reports Volume 9, Issue 10, October 2024, Pages 3053-3056] Tekijä David Massicotte-Azarniouch, Daniel J. Crona, Priscilla Karnabi, Bhadran Bose, Patrick H. Nachman, Marc Carrier, Mark Canney, David W. Johnson, Taewoo Lee, Raja Ramachandran, Vivekanand Jha, Nigel S. Key, Vimal K. Derebail

Hae kokoteksti

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study Tekijä Robert Klamroth, Michael Recht, Nigel S. Key, Wolfgang Miesbach, Steven W. Pipe, Radoslaw Kaczmarek, Douglass Drelich, Blanca Salazar, Sandra Le Quellec, Paul E. Monahan, Nicholas Galante, Paul van der Valk, Jacqueline Tarrant

Hae kokoteksti

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model Tekijä Fatima Trebak, Mohammad O. Sako, Steven P. Grover, Karnsasin Seanoon, Izabela Pawlinski, Chatphatai Moonla, Michael W. Henderson, Vimal K. Derebail, Dougald M. Monroe, Patrick Ellsworth, Rafal Pawlinski, Malgorzata Kasztan, Nigel S. Key

Hae kokoteksti

Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome Tekijä David Massicotte Azarniouch, Daniel J. Crona, Priscilla Karnabi, Bhadran Bose, Patrick H. Nachman, Marc Carrier, Mark Canney, David W. Johnson, Taewoo Lee, Raja Ramachandran, Vivekanand Jha, Nigel S. Key, Vimal K. Derebail

Hae kokoteksti

Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years Tekijä Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe

Hae kokoteksti

Blood-storage duration affects hematological and metabolic profiles in patients with sickle cell disease receiving transfusions Tekijä Matthew S. Karafin, Abby L. Grier, Ross M. Fasano, Anton Ilich, David Wichlan, Ada Chang, Sonjile M. James, Hailly E. Butler, Oleg Kolupaev, Melissa C. Caughey, Daniel J. Stephenson, Julie A. Reisz, Nigel S. Key, Joshua J. Field, Jane A. Little, Steven L. Spitalnik, Angelo D’Alessandro

Hae kokoteksti

Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results Tekijä Andrew D. Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V. Quon, Adam Giermasz, Gili Kenet, Gillian Lowe, Nigel S. Key, Carolyn M. Millar, Steven W. Pipe, Sheng-Chieh Chou, Robert Klamroth, Jane Mason, Hervé Chambost, Flora Peyvandi, Elaine Majerus, Dominic Pepperell, Chee Wee Tan, Hua Yu, Konstantia-Maria Chavele, Margareth C. Ozelo

Hae kokoteksti

Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial Tekijä Andrew D. Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V. Quon, Adam Giermasz, Maria Fernanda López Fernández, Gili Kenet, Gillian Lowe, Nigel S. Key, Carolyn M. Millar, Steven W. Pipe, Bella Madan, Sheng-Chieh Chou, Robert Klamroth, Jane Mason, Hervé Chambost, Flora Peyvandi, Elaine Majerus, Dominic Pepperell, Christine Rivat, Hua Yu, Tara M. Robinson, Margareth C. Ozelo

Hae kokoteksti

A cross-sectional analysis of cardiovascular disease in the hemophilia population Tekijä Suman L. Sood, Dunlei Cheng, Margaret Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco-Johnson, Adam Cuker, Christine Kempton, Tzu-Fei Wang, M. Elaine Eyster, Philip Kuriakose, Annette von Drygalski, Joan Cox Gill, Allison Wheeler, Peter Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall Corson, Crystal Watson, Barbara A. Konkle

Hae kokoteksti

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype Tekijä Francesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, Alessandro Casini, Giancarlo Castaman, Rezan Abdul‐Kadir, Erik Berntorp, Imre Bodó, Manon Degenaar‐Dujardin, Karin Fijnvandraat, Paolo Gresele, Nigel S. Key, Riitta Lassila, Frank W. G. Leebeek, David Lillicrap, Mike Makris, Stephan Meijer, Diego Mezzano, Patrizia Noris, Ingrid Pabinger, Margaret V. Ragni, David Silva, Alok Srivastava, Alberto Tosetto, Jerzy Windyga, Barbara Zieger

Hae kokoteksti